Revolution Medicines, Inc. Warrant (RVMDW NASDAQ) stock market data APIs
$9.9858
-0.49(-4.9%)
as of November 6, 2026
Try our APIs with
free plan!
Revolution Medicines, Inc. Warrant Financial Data Overview
Price chart is built with
Anychart
Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline consist of RAS(ON) inhibitors that binds RAS variants to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors to suppress cooperating targets and pathways that sustain RAS-addicted cancers. Its RAS(ON) inhibitors include daraxonrasib (RMC-6236), elironrasib G12C (RMC-6291) which is in early clinical development for the treatment of solid tumors, and zoldonrasib G12D (RMC-9805), which are in phase 3 registrational trial evaluating the combination of daraxonrasib with zoldonrasib in patients with 1L PDAC; and development candidates comprise RMC-5127 (G12V) which is in clinical trial, RMC-0708 (Q61H), that is in clinical trial; and RMC-8839 (G13C). Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.
Prev. Close
9.9858
Open
9.5007
High
10.0108
Low
9.1672
52 wk Range
0.3663-13.44
Market Cap
0
Revenue
742 K
Beta
1.431
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Revolution Medicines, Inc. Warrant data using free add-ons & libraries
Get Revolution Medicines, Inc. Warrant Fundamental Data
Revolution Medicines, Inc. Warrant Fundamental data includes:
- Net Revenue: 742 K
- EBITDA: -1 618 188 032
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Revolution Medicines, Inc. Warrant Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Revolution Medicines, Inc. Warrant News
New
Revolution Medicines reiterates $2.1B-$2.2B 2026 GAAP operating expense guidance following RASONQUE launch
Earnings Call Insights: Revolution Medicines (RVMD) Q3 2026 MANAGEMENT VIEW * "The third quarter marked a transformational period for Revolution Medicines" as the company said "the FDA approved RA...
Revolution Medicines (RVMD) Jumps 54% on Stellar Drug Trial Results
Revolution Medicines Inc. (NASDAQ:RVMD) is one of the 10 Stocks With Monster Returns. Revolution Medicines soared by 54.13 percent week-on-week, with sentiment primarily bolstered by the stellar resu...
A Long Elusive Lung Cancer Target May Finally Be Yielding to New Drugs
Early results presented at a cancer research conference showed tumor shrinkage and slowed disease progression in patients who had few other options. Continue Reading
Revolution Medicines to Present Updated Phase 1 Clinical Data for Zoldonrasib in Patients with Previously Treated KRAS G12D Non-Small Cell Lung Cancer at the 2026 AACR Annual Meeting
Revolution Medicines, Inc. REDWOOD CITY, Calif., April 19, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for...
Get Revolution Medicines, Inc. Warrant fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.